Press release
Central Nervous System (CNS) Therapeutics Market Size to Reach US$ 185.62 Billion During 2022-2027 | Industry Forecast, Report, Share, Trends, Growth
The latest research study "Central Nervous System (CNS) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global central nervous system (CNS) therapeutics market size reached US$ 121.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 185.62 Billion by 2027 exhibiting a growth rate (CAGR) of 7.10% during 2022-2027.Download free sample brochure: https://www.imarcgroup.com/central-nervous-system-therapeutics-market/requestsample
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
What is central nervous system (CNS) ?
The central nervous system (CNS) refers to an essential part of the nervous system that comprises of the brain and the spinal cord. It integrates the received information and that coordinates and controls the activities of all parts of the body. CNS therapeutics primarily includes anesthetics, anticonvulsants, CNS stimulants, muscle relaxants, narcotic analgesics, sedatives, etc. It is extensively adopted in the treatment procedures of Parkinson's disease, depression, Alzheimer's disease, epilepsy, traumatic brain, spinal cord injury, CNS cancer, etc.
Central Nervous System (CNS) Therapeutics Market Trends and Drivers:
The rising prevalence of mental illnesses and lifestyle-associated nervous system disorders, such as anxiety, depression, hypertension, etc., is among the key factors stimulating the central nervous system (CNS) therapeutics market. Apart from this, the expanding geriatric population, who are more prone to chronic neurological ailments, including Alzheimer's disease and Parkinson's disease, is also propelling the global market.
Besides this, the inflating popularity of generic neurologic drugs across developing countries, on account of their affordability, is further fueling the market growth. Additionally, the growing innovations in nervous system treatment procedures, such as the development of gene therapy, neurostimulation tools, and neural transplantation techniques, are also driving the global market. Furthermore, the introduction of novel drug-delivery systems that provide ease of administration and availability of different dosage forms is acting as another significant growth-inducing factor.
Moreover, the increasing focus among government bodies and non-government organizations on creating awareness regarding numerous nervous system disorders and the accessibility to several treatment options is further catalyzing the global market. Apart from this, the launch of favorable guidelines to support faster approvals of pipeline drugs for neurodegenerative diseases and clinical trials that encourage the entry of new products is expected to positively influence the central nervous system (CNS) therapeutics market over the forecasted period.
Click here to view detailed information with table of content: https://www.imarcgroup.com/central-nervous-system-therapeutics-market
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Disease:
• Neurodegenerative Diseases
o Alzheimer's Disease
o Parkinson's Disease
o Multiple Sclerosis
o Huntington's Disease
o Amyotrophic Lateral Sclerosis
o Others
• Neurovascular Diseases
• CNS Trauma
• Mental Health
o Anxiety Disorders
o Epilepsy
o Mood Disorders
o Psychotic Disorders
o Others
• Infectious Diseases
• CNS Cancer
• Others
Breakup by Application:
• Hospital
• Clinic
• Homecare
• Others
By Geography:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Also, Read Latest Research Reports by IMARC Group:
IVF Devices and Consumables Market Size: https://www.imarcgroup.com/ivf-devices-consumables-market
Anesthesia and Respiratory Devices Market Share: https://www.imarcgroup.com/anesthesia-respiratory-devices-market
Direct Fed Microbials Market Trends: https://www.imarcgroup.com/direct-fed-microbials-market
Coronary Stents Market Forecast: https://www.imarcgroup.com/coronary-stents-market
Bioabsorbable Stents Market Growth: https://www.imarcgroup.com/bioabsorbable-stents-market
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Central Nervous System (CNS) Therapeutics Market Size to Reach US$ 185.62 Billion During 2022-2027 | Industry Forecast, Report, Share, Trends, Growth here
News-ID: 2811454 • Views: …
More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India seafood…

India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025:
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2.50 Billion
Market Size in 2033: USD 5.90 Billion
Market Growth Rate (CAGR) 2025-2033: 10.03%
How Big is the India Mutual Funds Industry?
The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033.
Request…

Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview:
The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC…

Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay.
IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…
More Releases for CNS
CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0]
China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province.
According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,…
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886
This latest report…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and…
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the…
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575
Notes:
Production, means the output of CNS Therapeutics
Revenue, means the sales value of CNS Therapeutics
This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer, Inc. (USA)
Johnson & Johnson (USA)
Bristol-Myers Squibb…